Acutaas Chemicals Share Price Target 2026: Expert Forecast, Catalysts and Key Risks
- May 13, 2026
- Posted by: Neeraj Pandey
- Category: News
The Acutaas Chemicals share price target for 2026 stands at Rs 3,300 as per analyst estimates, implying approximately 20 percent upside from the current market price of Rs 2,750. Investors tracking the Acutaas Chemicals share price target 2026 need to understand the full picture including FY27 earnings catalysts, sector tailwinds, key risks, and the bull versus bear case scenarios. The Acutaas Chemicals share price target thesis is backed by the company’s industry position, strategic initiatives, and improving macro conditions. This article covers every dimension of the Acutaas Chemicals share price target updated May 2026.
Click Here – Get Free Investment Predictions
Acutaas Chemicals Company Overview
Acutaas Chemicals (NSE: ACUTAAS) is formerly Ami Organics, a leading R&D-driven specialty chemicals and pharmaceutical intermediates manufacturer, producing high-value chemicals for pharma, agrochemicals, semiconductor, and battery materials industries. At CMP Rs 2,750 against a 52 week range of Rs 1,040 to Rs 2,743, the stock currently trades at a meaningful discount to its 52 week high, creating a re-rating opportunity for investors tracking the Acutaas Chemicals share price target of Rs 3,300. The company’s market capitalisation stands at Rs 22,500 crore.
| Parameter | Value |
|---|---|
| NSE Ticker | ACUTAAS |
| Sector | Specialty Chemicals and Pharma Intermediates |
| CMP May 2026 | Rs 2,750 |
| 52 Week High | Rs 2,743 |
| 52 Week Low | Rs 1,040 |
| Market Cap | Rs 22,500 crore |
| Trailing P/E | 68x |
| 12M Analyst Target | Rs 3,300 |
| Bull Case Target | Rs 4,000 |
| Bear Case Target | Rs 2,200 |
Why Is Acutaas Chemicals Share Price Target Set at Rs 3,300 for 2026
FY27 Earnings Delivery and Revenue Acceleration
FY27 is the pivotal year for the earnings recovery thesis underpinning the Acutaas Chemicals share price target 2026 of Rs 3,300. Analysts project 15 to 20 percent PAT growth in FY27 as operational leverage and strategic investments begin contributing to the top line. Q4 FY26 results with positive FY27 guidance are the immediate trigger for re-rating toward the Acutaas Chemicals share price target forecast. This FY27 earnings delivery is the primary variable that bridges the current CMP of Rs 2,750 with the Acutaas Chemicals share price target of Rs 3,300.
Structural Sector Tailwinds in Specialty Chemicals and Pharma Intermediates
India’s specialty chemicals sector is benefiting from China-plus-one sourcing shifts, rising domestic manufacturing, and increasing export demand for high-value chemicals. Acutaas Chemicals’s market position and operational expertise create a compounding growth runway that directly supports the Acutaas Chemicals share price target consensus of Rs 3,300. Improving sectoral fundamentals are expected to accelerate earnings momentum through FY27, reinforcing the Acutaas Chemicals share price target 2026 bull case of Rs 4,000.
RBI Rate Cut Cycle and Lower Cost of Capital
The RBI rate cut cycle which commenced in early 2026 reduces Acutaas Chemicals’s borrowing costs and stimulates demand across its end markets. Lower interest costs improve EBITDA to PAT conversion, directly expanding EPS and supporting the Acutaas Chemicals share price target 2026 of Rs 3,300. Any further rate cuts through FY27 compound this benefit and add upside optionality toward the bull case Acutaas Chemicals share price target of Rs 4,000.
Union Budget 2026 Policy Support
Union Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption demand incentives create a positive policy backdrop for Acutaas Chemicals’s Specialty Chemicals and Pharma Intermediates business. These policy tailwinds directly support the Acutaas Chemicals share price target 2026 bull case and improve the probability of achieving the Rs 3,300 analyst estimate over the next 12 months.
Improving FII Flows Post US Tariff Shock
As macro conditions normalise post the April 2026 US tariff shock, FII flows into quality Indian companies are expected to recover through FY27, directly supporting the Acutaas Chemicals share price target of Rs 3,300. Acutaas Chemicals’s valuation at 68x P/E relative to sector peers positions it as a potential beneficiary of institutional reallocation as sentiment normalises across Indian equities.
Screen the best stocks on the Univest Screener.
Acutaas Chemicals Share Price Targets: Short Term, 12 Month, and Long Term
Short Term Target: 3 to 6 Months
The short term Acutaas Chemicals share price target is anchored to the 52 week low support zone near Rs 1,040. In the 3 to 6 month timeframe, a recovery toward 10 to 15 percent above current levels is the base case if Q4 FY26 results confirm the earnings recovery trajectory. Any positive operational update could serve as a near-term re-rating trigger toward the full Acutaas Chemicals share price target 2026 of Rs 3,300.
12 Month Acutaas Chemicals Share Price Target 2026
The 12 month Acutaas Chemicals share price target 2026 is Rs 3,300, implying approximately 20 percent upside from CMP Rs 2,750. This base case assumes in-line FY27 earnings delivery, partial normalisation of FII flows, and continued execution on strategic priorities. Track the live Acutaas Chemicals share price target data on NSE ticker ACUTAAS.
Long Term Target: FY27 to FY28
For investors with a 2 to 3 year horizon, the long term Acutaas Chemicals share price target is Rs 4,000 in the bull case. Full FY27-FY28 earnings delivery, strategic expansion, and sector re-rating toward higher peer multiples are the conditions required. The long-term Acutaas Chemicals share price target thesis rests on Acutaas Chemicals’s market leadership and expanding addressable opportunity in the Specialty Chemicals and Pharma Intermediates space.
Bull Case and Bear Case for Acutaas Chemicals Share Price Target
Bull Case Acutaas Chemicals Share Price Target Rs 4,000
The bull case for the Acutaas Chemicals share price target of Rs 4,000 materialises if FY27 earnings exceed analyst estimates, sector tailwinds accelerate beyond consensus, and FII flows return to quality Indian names. Under this scenario, the stock re-rates toward higher earnings multiples, making the Acutaas Chemicals share price target of Rs 4,000 achievable within FY27 to FY28.
Bear Case Acutaas Chemicals Share Price Target Rs 2,200
The bear case sees the Acutaas Chemicals share price target testing Rs 2,200 if FY27 earnings guidance disappoints and FII outflows from Indian equities persist. At Rs 2,200, the stock would revisit near the 52 week low support zone of Rs 1,040, requiring a full reassessment of the Acutaas Chemicals share price target thesis before fresh targets can be assigned.
| Scenario | Price Target | Conditions |
|---|---|---|
| Bull Case | Rs 4,000 | FY27 earnings beat, sector re-rating, FII inflows, macro normalisation |
| Base Case Analyst Forecast | Rs 3,300 | In-line FY27 delivery, partial FII recovery, steady execution |
| Bear Case | Rs 2,200 | FY27 guidance cut, earnings miss, persistent FII outflows |
Key Risks to the Acutaas Chemicals Share Price Target 2026
US Tariff Macro Headwind
The 26 percent US reciprocal tariff announced April 2, 2026 created FII outflow pressure across Indian equities including Acutaas Chemicals. Prolonged trade tension or global demand slowdown remains a key downside risk to the Acutaas Chemicals share price target 2026 of Rs 3,300.
Valuation and Earnings Miss Risk
At 68x P/E, any FY27 earnings miss or guidance cut could trigger multiple compression, posing the most immediate risk to the Acutaas Chemicals share price target 2026 of Rs 3,300. Investors should monitor quarterly results closely for confirmation of the earnings recovery trajectory.
Competitive Pressure in Specialty Chemicals and Pharma Intermediates
Intensifying competition in the Specialty Chemicals and Pharma Intermediates space could compress Acutaas Chemicals’s pricing power and market share over the medium term. This is a structural risk that investors should weigh when evaluating the Acutaas Chemicals share price target of Rs 3,300 at current levels.
FII Selling Pressure and Liquidity Risk
Global risk-off events can trigger institutional selling, disconnecting price from fundamental value. Sustained FII outflows could delay re-rating toward the Acutaas Chemicals share price target regardless of company-level improvement through FY27.
How to Invest in Acutaas Chemicals
- Research the Fundamentals: Analyse Acutaas Chemicals’s quarterly results, balance sheet, and strategic developments before making any investment decision based on the Acutaas Chemicals share price target 2026 of Rs 3,300.
- Open a Demat Account: Buy Acutaas Chemicals (NSE: ACUTAAS) through any SEBI registered broker to invest with full regulatory protection.
- Plan Your Entry: Key support is near Rs 1,040 at the 52 week low. A confirmed FY27 earnings uptick would strengthen the entry case toward the Acutaas Chemicals share price target of Rs 3,300.
- Position Sizing: Allocate a maximum of 3 to 5 percent of your portfolio to any single stock to manage concentration and liquidity risk effectively.
- Consult a SEBI Registered Advisor: Always seek guidance from a SEBI registered financial advisor before investing based on any Acutaas Chemicals share price target estimate. SEBI Registration No. INH000013776.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
FAQs on Acutaas Chemicals Share Price Target 2026
What is the Acutaas Chemicals share price target for 2026?
The Acutaas Chemicals share price target 2026 is Rs 3,300 based on analyst estimates, implying approximately 20 percent upside from the current CMP of Rs 2,750. The bull case is Rs 4,000 and the bear case is Rs 2,200.
Is Acutaas Chemicals a good buy at CMP Rs 2,750?
At Rs 2,750, the stock offers potential upside to the Acutaas Chemicals share price target 2026 of Rs 3,300 if FY27 earnings recover as projected. Investment suitability depends on individual risk tolerance and time horizon. Consult a SEBI registered financial advisor before investing.
What is the 52 week high and low of Acutaas Chemicals?
The 52 week high of Acutaas Chemicals is Rs 2,743 and the 52 week low is Rs 1,040. At CMP Rs 2,750, the stock is below its 52 week peak, creating upside potential to the Acutaas Chemicals share price target 2026 of Rs 3,300.
What are the main risks to the Acutaas Chemicals share price target?
Key risks to the Acutaas Chemicals share price target of Rs 3,300 include US tariff-driven FII selling, earnings miss risk, competitive pressure in Specialty Chemicals and Pharma Intermediates, and broader market volatility. Monitor quarterly results for confirmation of the recovery trajectory.
What are the key catalysts for the Acutaas Chemicals share price target?
Primary catalysts for the Acutaas Chemicals share price target 2026 include FY27 PAT recovery, sector tailwinds in Specialty Chemicals and Pharma Intermediates, RBI rate cut support, Budget policy uplift, and FII flow normalisation into quality Indian equities through FY27.
Where can I track Acutaas Chemicals live price and analyst data?
Track the Acutaas Chemicals share price target and live price on NSE (ticker: ACUTAAS). Financial data platforms provide quarterly results, margins, and peer comparisons to assess the Rs 3,300 analyst estimate thesis in real time.
What is the Acutaas Chemicals share price target for 2027?
For FY27 to FY28, the long term Acutaas Chemicals share price target is Rs 4,000 in the bull case, assuming earnings acceleration, sector re-rating, and FII flow recovery. Consult a SEBI registered financial advisor for personalised investment guidance.
How can I buy Acutaas Chemicals shares?
You can buy Acutaas Chemicals (NSE: ACUTAAS) through any SEBI registered stockbroker by opening a Demat and trading account online. Research the Acutaas Chemicals share price target on verified financial platforms and always set a disciplined entry, target, and stop loss before investing.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available data as of May 2026. Consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.
